Regular Treatment With Aspirin 300 mg/day After Desensitization in Patients With N-ERD: 12-Year Results

KAYA S. B., Cakmak M. E., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.

TURKISH THORACIC JOURNAL, cilt.22, sa.5, ss.376-380, 2021 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 5
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5152/turkthoracj.2021.0298
  • Dergi Adı: TURKISH THORACIC JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.376-380
  • Anahtar Kelimeler: Aspirin desensitization, asthma, endoscopic sinus surgery, nasal polyp, NSAID hypersensitivity, LONG-TERM TREATMENT, OUTCOMES
  • Hacettepe Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Aspirin desensitization is recommended for patients with nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity, in whom asthma is uncontrolled despite medical treatment, and/or frequent endoscopic sinus surgery (ESS) is required due to nasal polyps. There are few studies in the literature on long-term follow-up of patients undergoing regular aspirin treatment after desensitization. This study aims to evaluate the effect of regular aspirin treatment on respiratory function, symptom control, quality of life, and the number of nasal surgeries required during a period of 12 years.